Saranda Snyder Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1353 Ridge Rd, Stillwater, PA 17878 Phone: 570-401-9211 |
News Archive
BioAtla LLC, a biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, today announced that it has entered into a license and option agreement with Pfizer Inc. to advance the development and commercialization of a new class of antibody therapeutics based on BioAtla's CAB platform and utilizing Pfizer's proprietary antibody drug conjugate (ADC) payloads.
In Canada and the U.S., doctors are increasingly being encouraged to try to identify depression in children and adolescents - even if they do not have obvious indications of the disease. In order to do so, the physicians often use short questionnaires that ask about symptoms of depression
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of suggested guidelines on establishing research partnerships with patients.
More than 80 percent of hepatitis C patients in each arm of the Phase 2 Study C208 achieved a sustained viral response (SVR) with a telaprevir-based regimen according to results of an intent-to-treat (ITT) analysis announced today by Vertex Pharmaceuticals Incorporated.
› Verified 2 days ago